# Ovarian Dendritic Cell Vaccine Trial

> **NCT00703105** · PHASE2 · UNKNOWN · sponsor: **Loyola University** · enrollment: 36 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** DC vaccination

## Key facts

- **NCT ID:** NCT00703105
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703105, "Ovarian Dendritic Cell Vaccine Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00703105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*